DOCSLIB.ORG

LONG-TERM MEMBERS 25+ Years of Membership

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

LONG-TERM MEMBERS 25+ Years of Membership Stuart A. Aaronson, MD Stephen P. Ackland, MBBS Carol Aghajanian, MD Steven A. Akman, MD Icahn School of Medicine at Mount Sinai University of Newcastle Memorial Sloan Kettering Cancer Center Roper St. Francis Healthcare United States Australia United States United States Active Member Active Member Active Member Active Member 38 Years of Membership 33 Years of Membership 27 Years of Membership 35 Years of Membership Cory Abate-Shen, PhD Edward M. Acton, PhD Irina U. Agoulnik, PhD Emmanuel T. Akporiaye, PhD Columbia University Irving Medical United States Florida International University Verana Therapeutics Center Emeritus Member United States United States United States 42 Years of Membership Active Member Emeritus Member Active Member 25 Years of Membership 31 Years of Membership 26 Years of Membership David J. Adams, PhD Duke University Medical Center Imran Ahmad, PhD Ala-Eddin Al Moustafa, PhD James L. Abbruzzese, MD United States Northwestern Medicine McGill University Duke University Emeritus Member United States Canada United States 32 Years of Membership Active Member Active Member Active Member 25 Years of Membership 26 Years of Membership 32 Years of Membership Gregory P. Adams, PhD Elucida Oncology Nihal Ahmad, PhD Abdul Al Saadi, PhD Ehtesham A. Abdi, MBBS United States Univ. of Wisconsin Madison Sch. of Med. William Beaumont Hospital The Tweed Hospital Active Member & Public Health United States Australia 29 Years of Membership United States Emeritus Member Emeritus Member Active Member 52 Years of Membership 33 Years of Membership Lucile L. Adams-Campbell, PhD 25 Years of Membership Georgetown Lombardi Comprehensive Suresh K. Alahari, PhD Kaoru Abe, MD Cancer Ctr. Khalil Ahmed, PhD LSU Health New Orleans Yokohama Rosai Hospital United States University of Minnesota United States Japan Active Member United States Active Member Emeritus Member 26 Years of Membership Emeritus Member 27 Years of Membership 25 Years of Membership 25 Years of Membership Peter C. Adamson, MD Moulay A. Alaoui-Jamali, PhD Herbert T. Abelson, MD Sanofi Tauseef Ahmed, MD Segal Cancer Ctr. University of Chicago United States New York Medical College Canada United States Active Member United States Active Member Emeritus Member 31 Years of Membership Emeritus Member 29 Years of Membership 48 Years of Membership 37 Years of Membership Richard H. Adamson, PhD Kathy S. Albain, MD Elliot Abemayor, MD, PhD TPN Associates, LLC Myung-Ju Ahn, MD, PhD Loyola University Medical Center UCLA David Geffen School of Medicine United States Samsung Medical Center United States United States Active Member Korea, Republic of Active Member Active Member 57 Years of Membership Active Member 33 Years of Membership 32 Years of Membership 26 Years of Membership Douglas R. Adkins, MD Mark R. Albertini, MD Richard Joel Ablin, PhD Washington University School of Mamoun Ahram, PhD University of Wisconsin Carbone Cancer University of Arizona Medicine University of Jordan Center United States United States Jordan United States Emeritus Member Active Member Active Member Active Member 44 Years of Membership 29 Years of Membership 25 Years of Membership 27 Years of Membership Ross A. Abrams, MD Samuel Evans Adunyah, PhD Nita Ahuja, MD Pierre J. L. Alberto, MD Rush University Medical Center Meharry Medical College Yale School of Medicine Switzerland United States United States United States Emeritus Member Emeritus Member Active Member Active Member 42 Years of Membership 39 Years of Membership 32 Years of Membership 25 Years of Membership David S. Alberts, MD Tinya J. Abrams, PhD Stefan Aebi, MD Luisa Airoldi, PhD University of Arizona Cancer Center Novartis (Cambridge, MA) Lucerne Cantonal Hospital Mario Negri Institute for United States United States Switzerland Pharmacological Research (Milan) Emeritus Member Active Member Active Member Italy 46 Years of Membership 28 Years of Membership 26 Years of Membership Emeritus Member 29 Years of Membership Adriana Albini, PhD Hernan F. Acevedo, PhD Rajesh Agarwal, PhD IRCCS MultiMedica Allegheny General Hospital University of Colorado Denver, Skaggs Yukihiro Akao, MD Italy United States School of Pharmacy Gifu Univ. Active Member Emeritus Member United States Japan 33 Years of Membership 44 Years of Membership Active Member Emeritus Member 30 Years of Membership 25 Years of Membership Anthony P. Albino, PhD Mildred Acevedo-Duncan, PhD Vector Group Ltd. University of South Florida Bharat B. Aggarwal, PhD Shin-ichi Akiyama United States United States UT MD Anderson Cancer Center Japan Emeritus Member Active Member United States Emeritus Member 40 Years of Membership 29 Years of Membership Emeritus Member 28 Years of Membership 28 Years of Membership 1 Claudio Marcelo Aldaz, MD Frederick W. Alt, PhD Kenning M. Anderson, MD, PhD Ettore Appella, MD UT MD Anderson Cancer Center Boston Children’s Hospital Hektoen Institute of Medicine National Cancer Institute United States United States United States United States Active Member Active Member Emeritus Member Emeritus Member 33 Years of Membership 32 Years of Membership 43 Years of Membership 52 Years of Membership Francis Ali-Osman, DSc Susan E. Alters, D Phil Kristin E. Anderson, PhD Gulshan Ara, PhD Duke Univ. Comprehensive Cancer Ctr. Alters BioScience Consulting University of Minnesota, School of United States United States United States Public Health Emeritus Member Emeritus Member Active Member United States 31 Years of Membership 33 Years of Membership 25 Years of Membership Emeritus Member 29 Years of Membership Wadih Arap, MD, PhD Kari K. Alitalo, MD, PhD Enrique Alvarez, DVM Rutgers Cancer Institute of New Jersey University of Helsinki Kleo Pharmaceuticals Marshall W. Anderson, PhD United States Finland United States Medical College of Wisconsin Active Member Active Member Active Member United States 30 Years of Membership 31 Years of Membership 31 Years of Membership Emeritus Member 39 Years of Membership Jeffrey M. Arbeit, MD Ayad M. Al-Katib, MD Ronald David Alvarez, MD Jeffrey Arbeit Biomedical Consulting Wayne State University School of Vanderbilt University Paul N. Anderson, MD United States Medicine United States Medical Oncology P.C. Active Member United States Active Member United States 34 Years of Membership Emeritus Member 25 Years of Membership Active Member 33 Years of Membership 47 Years of Membership Nadir Arber, MD William L. Alworth, PhD Tel Aviv Sourasky Medical Ctr. Carmen J. Allegra, MD United States Peter M. Anderson, MD, PhD Israel University of Florida Emeritus Member Cleveland Clinic Active Member United States 31 Years of Membership United States 27 Years of Membership Active Member Emeritus Member 32 Years of Membership Dino Amadori, MD 32 Years of Membership Susan G. Arbuck, MD Romagnolo Inst. for the Study of Susan G Arbuck MD LLC Steven L. Allen, MD Tumors Dino Amadori Tom Anderson, MD United States Northwell Health Italy United States Emeritus Member United States Emeritus Member Emeritus Member 34 Years of Membership Active Member 28 Years of Membership 45 Years of Membership 27 Years of Membership Federico Maria Arcamone, PhD Verena R. Amberger-Murphy, D Phil Borje S. Andersson, MD, PhD Italy Theresa M. Allen, PhD Cancer Trials Ireland UT MD Anderson Cancer Center Emeritus Member University of Alberta Ireland United States 36 Years of Membership Canada Affiliate Member Active Member Emeritus Member 26 Years of Membership 29 Years of Membership Michael C. Archer, PhD 29 Years of Membership University of Toronto Christine B. Ambrosone, PhD Michael Andreeff, MD, PhD Canada Michael C. Alley, PhD Roswell Park Comprehensive Cancer UT MD Anderson Cancer Center Emeritus Member National Cancer Institute at Frederick Center United States 40 Years of Membership United States United States Active Member Emeritus Member Active Member 43 Years of Membership Bach Ardalan, MD 36 Years of Membership 28 Years of Membership Univ. of Miami Sylvester Comprehensive Paul A. Andrews, PhD Cancer Ctr. David C. Allison, MD, PhD Stefan Ambs, PhD Dirigo Nonclinical Consulting, LLC United States University of Toledo National Cancer Institute United States Active Member United States United States Emeritus Member 42 Years of Membership Active Member Active Member 36 Years of Membership 33 Years of Membership 25 Years of Membership Pablo Arenaz, PhD Lowell Brian Anthony, MD Texas A&M International University D. Craig Allred, MD Magid H. Amer, MD University of Kentucky (TAMIU) Washington University School of United States United States United States Medicine Emeritus Member Active Member Emeritus Member United States 41 Years of Membership 31 Years of Membership 36 Years of Membership Emeritus Member 28 Years of Membership Bruce N. Ames, PhD Karen H. Antman, MD Paul A. Aristoff, PhD Children’s Hospital Oakland Rsch Inst Boston Univ. School of Medicine Aristoff Consulting Alex Almasan, PhD United States United States United States Cleveland Clinic Emeritus Member Active Member Emeritus Member United States 44 Years of Membership 40 Years of Membership 31 Years of Membership Active Member 25 Years of Membership Matthew M. Ames, PhD Hoda Anton-Culver, PhD Ralph B. Arlinghaus, PhD Mayo Clinic College of Medicine and University of California, Irvine UT MD Anderson Cancer Center Isaf Al-Nabulsi, PhD Science United States United States U.S. Department of Energy United States Active Member Emeritus Member United States Emeritus Member 43 Years of Membership 36 Years of Membership Active Member 42 Years of Membership 31 Years of Membership
Recommended publications
  • Of Aging: Wistar Researchers Shed New Light on Getting Old

    Of Aging: Wistar Researchers Shed New Light on Getting Old

    ocus F Summer 2008 The Science of Aging: Wistar researchers shed new light on getting old Wistar Launches High-Tech Research Center The Federal Funding Crunch: What Does It Mean for Wistar? FROM THE PRESIDENT Wistar: Research at the Frontier he Wistar Institute has a pioneering tradition. TCaspar Wistar, for whom the Institute is named, was a forward-thinking 18th-century physician who wrote the first American anatomy textbook and was an early proponent of vaccination. His great-nephew, Insti- tute founder Isaac J. Wistar, was a pioneer in his own right who trekked west by wagon train to spend winters as a trapper in the wilds of California. Isaac Wistar founded The Wistar Institute in 1892 with the stated intention of creating a center for “new and original research” in the biological and medical sci- Peter Olson ences. In the ensuing century, Wistar lived up to that charge, and it continues to do so today. massive amounts of data and pinpoint disease-causing Wistar’s first scientific advisory board, convened in genes and proteins. The center supports work like that of 1905, declared research as the Institute’s principal objec- David W. Speicher, Ph.D., who is developing blood tests tive and specified three areas of focus: comparative for the early detection of the deadliest cancers. anatomy, embryology, and neurology—fields that repre- Likewise, the Institute’s new chemical screening facil- sented the leading edge of science and medicine at the ity, set to launch this fall, will allow investigators to turn of the century. screen vast numbers of compounds and identify those The Institute’s research focus has evolved over the years.
  • The Fourth Report of Senior Pay and Perks in UK Universities History This

    The Fourth Report of Senior Pay and Perks in UK Universities History This

    Transparency at the top? The fourth report of senior pay and perks in UK universities History This is the fourth report on pay and perks at the top of British higher education institutions (HEIs) to be published by the University and College Union (UCU). It forms part of the union’s ongoing campaign for greater transparency in higher education, including the rationale behind senior pay rises. UCU submitted a Freedom of Information (FoI) request to 158 HEIs in October 2017. This followed similar requests submitted in 2016, 2015 and 2014. All requests were designed to shine a light on the arbitrary nature of senior pay and perks in universities, and support the union’s call for reform. The basis for this report The FoI request that forms the basis of this report was sent to 158 (HEIs). It requested details of vice-chancellors’ (or head of institution if known by a different title) salaries and those of other senior post-holders earning over £100,000 at the institution during the academic year of 2016/17 (1 August 2016 to 31 July 2017). It also asked for details of flights, spending on hotels, spending on expenses and if the vice-chancellor was provided with accommodation by the university. Finally, we requested to know whether or not the vice-chancellor was a member of the remuneration committee, and requested a copy of the most recently ratified minutes of the institution’s remuneration committee. Variety of responses The questions on expenditure on flights, hotels, expenses and accommodation for vice-chancellors elicited a huge variation in responses with many institutions deploying exemptions under the Freedom of Information Act to avoid providing data.
  • 10 Officers of the University 2003-04

    10 Officers of the University 2003-04

    FACT BOOK 2003-04 Office of the Provost Institutional Research PREFACE May 2004 This is the sixteenth annual edition of the Seton Hall University FACT BOOK. It is intended to serve the routine statistical and informational needs of faculty, administration, staff, and alumni. The Office of Institutional Research has attempted to offer relevant information on the principal characteristics and strengths of Seton Hall University. In all areas, we have attempted to gather the current and most accurate data available. Please notify the Office of Institutional Research if you are aware of any factual errors. You are encouraged to offer comments and suggestions for improvement of future editions and the expansion of reporting areas. Appreciation is extended to the many offices that have assisted in the research necessary for compiling this FACT BOOK. Mel J. Shay Connie L. Beale Provost and Director of Quantitative Analysis Executive Vice President for Academic Affairs Office of Institutional Research TABLE OF CONTENTS THE UNIVERSITY MISSION STATEMENT.........................................................................................................................3 SESQUICENTENNIAL VISION STATEMENT ............................................................................................3 BRIEF HISTORY .................................................................................................................................4 HISTORICAL MILESTONES ..................................................................................................................5
  • Womencount: Leaders in Higher Education 2016

    Womencount: Leaders in Higher Education 2016

    WomenCount Leaders in Higher Education 2016 A report by Norma Jarboe OBE ‘There’s no magic about getting a good gender balance – just dogged repetition of what a high priority it is and a determination to seek out strong women candidates who could hold their own against any competition.’ WomenCount ‘If universities inhibit the progression of talented female staff, they in turn are unable to reach their full potential. We know that universities make a huge contribution to society through research, teaching and partnerships with businesses, among many other activities.’ Professor Dame Athene Donald, Professor of Experimental Physics and Master of Churchill College, University of Cambridge WomenCount are very grateful to Perrett Laver for their support, the Government Equalities Office for their enagagement and Imperial College London for hosting the launch of this report on 2 March 2016. Cover quotation: Sir Nicholas Montagu, Chair of Council, Queen Mary University of London. Published by WomenCount © March 2016, all rights reserved. www.women-count.org Designed and produced by Graffeg. WomenCount: Leaders in Higher Education 2016 Contents 3 Foreword 4 Executive summary 5 Introduction 6 Collective action 9 Collegial governance: diversity challenge or opportunity? 10 Governing bodies: women’s representation on the rise 11 Governing bodies: the balancing act 12 Chairs: few seats for women 14 Vice-Chancellors: barely a fifth are women 15 Chair and Vice-Chancellor teams 16 Executive teams: a pipeline of women leaders 17 Academic heads: less than a third are women 19 HEI income impact women’s leadership 21 Mapping Women’s Leadership in HEIs 22 Reflections on the research 27 The Index 37 Biographies of new Chairs 42 Biographies of new Vice-Chancellors 47 About WomenCount and the author 1 Foreword ‘Gender equality is not a matter of being nice to women.
  • Il Est Un Petit Honneur «Qui Fait Grand Plaisir!» Michèle Thibodeau-Deguire a Accédé À L’Académie Des Grands Montréalais En 2001

    Il Est Un Petit Honneur «Qui Fait Grand Plaisir!» Michèle Thibodeau-Deguire a Accédé À L’Académie Des Grands Montréalais En 2001

    LE DEVOIR, LE MERCREDI 16 NOVEMBRE 2011 MONTREAL CAHIER C LES GRANDS MONTRÉALAIS Sid Stevens Frédéric Back Pierre Fortin est le Grand Montréalais devient à 87 ans et Aldo Bensadoun en 2011 le Grand Mont- rejoignent du secteur social réalais culturel la communauté Page 3 Page 5 Pages 4 et 6 JACQUES NADEAU LE DEVOIR Centraide encourage le développement du réseau des intervenants au sein de chaque quartier de Montréal. Il est un petit honneur «qui fait grand plaisir!» Michèle Thibodeau-DeGuire a accédé à l’Académie des Grands Montréalais en 2001 En 2001, Michèle Thibodeau-DeGuire, présidente et directri- police, l’école, les organismes communautaires, le CLSC, etc., ce générale de Centraide du Grand Montréal, s’est vu décer- travaillent dans le même sens ner le titre de Grand Montréalais, un honneur qui lui a fait pour trouver des solutions avec réellement plaisir. «C’est très, très, très excitant, lance tout à les citoyens, indique Mme Thi- fait joyeusement cette Acadienne de souche. C’est probable- bodeau-DeGuire. Nous finan- çons donc des tables de concerta- ment même, de tous les honneurs que j’ai reçus, celui qui tion depuis près de vingt ans, m’a le plus touchée!» afin de réunir les divers interve- nants pour qu’ils s’entendent sur CLAUDE LAFLEUR l’un ou l’autre des quatre les priorités de leur quartier. La champs d’activité — écono- table réunit ceux qui possèdent ela m’a même mique, social, culturel et une partie de la solution, ce qui surprise, se scientifique. Il y a ensuite un a déjà tout un impact.» « souvient Mi- petit groupe qui se réunit chèle Thibo- pour établir une courte liste 2011 sera deau-DeGuire, — trois ou quatre noms par une bonne année nomméeC «Grande Montréalai- secteur d’activité.
  • Company Coverage Report

    Company Coverage Report

    Company Coverage Report th Coverage initiated June 19 , 2009 Aurgalys is contracted by Onxeo to provide equity research Mickael Dubourd, Ph.D., SFAF Paris & Evry, France Onxeo E URONEXT : ONXEO [FR0010095596 – C OMPARTMENT C] August 1st, 2014 Share Price: €7.19 Onxeo, leader in orphan oncology (as of August 1st, 2014) Onxeo resulted from the merger of French BioAlliance Estimated price: Pharma and Danish Topotarget, both involved in orphan drug development for cancer. The combined entity will benefit €11.12 from experienced teams in this field and from a strong portfolio of products in late stage development. August 1st, High/Low since 01.01.14 11.74/4.30 2014, was Onxeo’s first day of trading on both Euronext Paris (€) and Nasdaq OMX Copenhagen. We are taking this opportunity to review Onxeo’s business strategy, drug Market Cap (€m) 226.4 pipeline and valuation. Three approved products, strong cash position, late stage Estimated Cash 27.0 development product portfolio Position (€m) Originating from BioAlliance's historical product portfolio, Sitavig and Estimated market cap. 350.1 Loramyc/Oravig have both been approved in the US and Europe. These two products will help generate short term revenues through licensing deals (€m) upfront and milestone payments as well as long term revenues with royalties nd Number of Shares (m) 31.5 on sales. Moreover, Beleodaq has just been approved in the US for 2 line Peripheral T-Cell Lymphoma (PTCL) and will be marketed by Spectrum Pharmaceutical. This is the first drug in the orphan oncology product portfolio to get US approval.
  • SETON HALL Ftniversity ^ R **• " SCHOOL of Dlplomact and INTERNATIONAL RELATIONS

    SETON HALL Ftniversity ^ R **• " SCHOOL of Dlplomact and INTERNATIONAL RELATIONS

    r t SETON HALL fTNIVERSITY ^ r **• " SCHOOL OF DlPLOMACt AND INTERNATIONAL RELATIONS His Excellency Kofi Annan Secretary-General of the United Nations Monday, February 5, 2001 • South Orange, New Jersey SETON HALlMNIVERSITY SCHOOL OF DIPLOMACY AND INTERNATIONAL RELATIONS His Excellency Kofi Annan Secretary-General of the United Nations Monday, February 5, 2001 • South Orange, New Jersey SCHOOL OF DIPLOMACY <S: INTERNATIONAL RELATIONS SETON HALL UNIVERSITY SETON HALL UNIVERSITY Honorary Degree Presentation and Address His Excellency Kofi Annan Secretary-General of the United Nations Monday, February 5, 2001 Seton Hall University Seton Hall University was founded in 1856 by Bishop James Roosevelt Bayley, the first bishop of Newark, who named it after his aunt, Mother Elizabeth Ann Seton, a pioneer in Catholic education and the first American-born saint. It is the oldest diocesan university in the United States. The University is made up of nine schools and colleges: • The College of Arts and Sciences, • The Stillman School of Business, • The School of Diplomacy and International Relations, • The College of Education and Human Services, • The School of Law, • The School of Graduate Medical Education, • The College of Nursing, • The Immaculate Conception Seminary School of Theology and • University College. The University has made a major commitment to information technology to improve systems and services and wire classrooms, residence halls and public spaces. In 1999 Se- ton Hall University was named the 16th most wired university in the U.S. and the top- ranked wired Catholic university by Yahoo! Internet Life magazine. The University also received the prestigious EDUCAUSE Award for Campus Networking Excellence.
  • 2015 Annual Report

    2015 Annual Report

    1 TABLE OF CONTENTS TABLE OF CONTENTS ............................................................................................................................. 2 HISTORY OF THE GAIRDNER FOUNDATION .................................................................................... 3 MISSION ...................................................................................................................................................... 3 NATIONAL AND STUDENT OUTREACH PROGRAMS ....................................................................... 4 MESSAGE FROM THE CHAIR ............................................................................................................... 5 MESSAGE FROM THE PRESIDENT/SCIENTIFIC DIRECTOR ......................................................... 6 2015 YEAR IN REVIEW ............................................................................................................................. 7 REPORT ON 2015 OBJECTIVES ............................................................................................................ 14 THE YEAR AHEAD: OBJECTIVES FOR 2016 ..................................................................................... 16 THE GAIRDNER FOUNDATION VALUES OUR 2015 SPONSORS ................................................... 18 GOVERNANCE ......................................................................................................................................... 20 MEDICAL REVIEW PANEL 2015 .........................................................................................................
  • 2016 Calendar of Events

    2016 Calendar of Events

    CALENDAR OF EVENTS OF EVENTS CALENDAR FEBRUARY 2 — MARCH 30, 2016 2 — MARCH 30, FEBRUARY EIGHT INSPIRED WEEKS OF DISCUSSIONS, PERFORMANCES, AND FILMS 2016 FEATURED TITLES FEATURED 2016 WELCOME 2016 FEATURED TITLES pg 2 WELCOME FROM THE CHAIR pg 3 YOUTH COMPANION BOOKS pg 4 ADDITIONAL READING SUGGESTIONS pg 5 DISCUSSION GROUPS AND QUESTIONS pg 6-7 FILM SCREENINGS pg 8-9 GENERAL EVENTS pg 10 EVENTS FOR CHILDREN, TEENS, AND FAMILIES pg 21 COMMUNITY PARTNERS pg 27 SPONSORS AND ACKNOWLEDGEMENTS pg 30 The centerpiece of 2016 One Book, One Philadelphia is author Charles Frazier’s historical novel Cold Mountain. Set at the end of the Civil War, Cold Mountain tells the heartrending story of Inman, a wounded Confederate soldier who walks away from the horrors of war to return home to his beloved, Ada. Cold Mountain BY CHARLES FRAZIER His perilous journey through the war-ravaged landscape of North Carolina Cold Mountain made publishing history when it topped the interweaves with Ada’s struggles to maintain her father’s farm as she awaits New York Times bestseller list for 61 weeks and sold 3 million Inman’s return. A compelling love story beats at the heart of Cold Mountain, copies. A richly detailed American epic, it is the story of a Civil propelling the action and keeping readers anxiously turning pages. War soldier journeying through a divided country to return Critics have praised Cold Mountain for its lyrical language, its reverential to the woman he loves, while she struggles to maintain her descriptions of the Southern landscape, and its powerful storytelling that dramatizes father’s farm and make sense of a new and troubling world.
  • Development of a Text to Speech System for Devanagari Konkani

    Development of a Text to Speech System for Devanagari Konkani

    DEVELOPMENT OF A TEXT TO SPEECH SYSTEM FOR DEVANAGARI KONKANI A Thesis submitted to Goa University for the award of the degree of Doctor of Philosophy in Computer Science and Technology By Nilesh B. Fal Dessai GOA UNIVERSITY Taleigao Plateau May 2017 Development of a Text to Speech System for Devanagari Konkani A Thesis submitted to Goa University for the award of the degree of Doctor of Philosophy in Computer Science and Technology By Nilesh B. Fal Dessai GOA UNIVERSITY Taleigao Plateau May 2017 Statement As required under the ordinance OB-9.9 of Goa University, I, Nilesh B. Fal Dessai, state that the present Thesis entitled, ‘Development of a Text to Speech System for Devanagari Konkani’ is my original contribution carried out under the supervision of Dr. Jyoti D. Pawar, Associate Professor, Department of Computer Science and Technology, Goa University and the same has not been submitted on any previous occasion. To the best of my knowledge, the present study is the first comprehensive work of its kind in the area mentioned. The literature related to the problem investigated has been cited. Due acknowledgments have been made whenever facilities and suggestions have been availed of. (Nilesh B. Fal Dessai) i Certificate This is to certify that the thesis entitled ‘Development of a Text to Speech System for Devanagari Konkani’, submitted by Nilesh B. Fal Dessai, for the award of the degree of Doctor of Philosophy in Computer Science and Technology is based on his original studies carried out under my supervision. The thesis or any part thereof has not been previously submitted for any other degree or diploma in any University or Institute.
  • To Professor Suzanne Cory AC

    To Professor Suzanne Cory AC

    Citation for the Award of the Doctor of Laws (Honoris Causa) to Professor Suzanne Cory AC When Suzanne Cory graduated from the Science Faculty at the University of Melbourne molecular biology was in its infancy. In her enthusiasm for this new science she pursued a PhD in Cambridge at the Medical Research Council’s famed Laboratory of Molecular Biology. Immersed in a culture of discovery, her pioneering PhD studies determined the sequence of a transfer RNA, utilising new technology developed by Fred Sanger, one of the three Nobel Laureates in the institute. After three years’ post‐doctoral work at the University of Geneva, Suzanne Cory returned to Australia with her husband, Jerry Adams, to the Walter and Eliza Hall Institute of Medical Research where they helped to introduce gene‐cloning technology to Australia. Since then, her long association with the Institute, including thirteen years as Director, and with the University of Melbourne, has been instrumental in building the international reputation of both institutions and the strength of the Parkville biomedical research network. Suzanne Cory has made major contributions to advancing the science of immunology, cancer and genetics, in a lifelong dynamic research partnership with Adams. Her work is published widely and cited frequently. The positions held by the many PhD candidates and Post‐Doctoral Fellows she has supervised demonstrate her intergenerational influence in developing scientific leaders for the future. The list of accolades and awards Suzanne Cory has received in recognition of her contributions to science is long and distinguished. She was elected a Fellow of the Australian Academy of Science in 1986 and since has been elected to numerous sister organisations across the globe.
  • Robert Wood Johnson Medical School Retired Faculty Association Newsletter

    Robert Wood Johnson Medical School Retired Faculty Association Newsletter

    ROBERT WOOD JOHNSON MEDICAL SCHOOL RETIRED FACULTY ASSOCIATION NEWSLETTER JANUARY 2017 VOLUME X, NO. 1 UPCOMING RFA MEETING IN VITRO FERTILIZATION: AN EMBRYONIC HISTORY “A Robot’s View of Our Ocean Planet” By Eckhard Kemmann, MD When I started my training in Obstetrics- Gynecology at SUNY Downstate-Kings County Hospital in Brooklyn almost five decades ago, infertility was encountered by ten percent of couples, and treatment options were limited and primarily surgical. My teachers and mentors at the institution represented different aspects of the presently evolving field of reproductive medicine. Dr. A. Siegler was a pioneer in tubal surgery and laparoscopy – in the 80s he would introduce laparoscopy to China. Dr. J. R. Jones was an early expert in reproductive hormone research, and Dr. A. Gemzell had come from Sweden where he faced mandatory retirement at the age of 65 and brought his expertise to the United States in the use of ovulation induction. Dr. Gemzell was the first to isolate and use (continued on page 2) Josh Kohut, Ph.D. Associate Professor, Department of Marine TABLE OF CONTENTS PAGE and Coastal Science, Rutgers University Upcoming Meeting 1 InT Vitro Fertilization: An Embryonic History Friday, March 3, 2017 by Eckhard Kemmann, MD 1 Noon – 1:30 p.m. Dean’s Conference Room I See You by Elliot Sultanik, MD, Class of 2016 4 Rutgers Robert Wood Johnson Medical School RWJMS RFA Election Results 5 Piscataway, New Jersey Retired RWJMS Faculty Program to Mentor Medical Students 5 All current and retired faculty, staff, and students Faculty Transition to Retirement Program 6 are welcome to attend.